Found: 29
Select item for more details and to access through your institution.
Use of Tumor Necrosis Factor-a Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.920333
- By:
- Publication type:
- Article
Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease.
- Published in:
- Nutrients, 2022, v. 14, n. 12, p. 2522, doi. 10.3390/nu14122522
- By:
- Publication type:
- Article
SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0211328
- By:
- Publication type:
- Article
Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 472, p. N.PAG, doi. 10.1126/scitranslmed.aap8914
- By:
- Publication type:
- Article
Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFα therapy in inflammatory bowel disease.
- Published in:
- PLoS ONE, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0256860
- By:
- Publication type:
- Article
Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn's Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8137, doi. 10.3390/ijms23158137
- By:
- Publication type:
- Article
Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis.
- Published in:
- Liver International, 2021, v. 41, n. 5, p. 1044, doi. 10.1111/liv.14831
- By:
- Publication type:
- Article
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2019, v. 321, n. 8, p. 773, doi. 10.1001/jama.2019.0709
- By:
- Publication type:
- Article
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
- Published in:
- Nature Genetics, 2010, v. 42, n. 12, p. 1118, doi. 10.1038/ng.717
- By:
- Publication type:
- Article
A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease.
- Published in:
- PLoS Genetics, 2011, v. 7, n. 1, p. 1, doi. 10.1371/journal.pgen.1001283
- By:
- Publication type:
- Article
Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohnʼs disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 675, doi. 10.1111/apt.17063
- By:
- Publication type:
- Article
Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 11, p. 1105, doi. 10.1111/apt.15762
- By:
- Publication type:
- Article
Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2010, v. 105, n. 2, p. 395, doi. 10.1038/ajg.2009.576
- By:
- Publication type:
- Article
Corrigendum: Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk.
- Published in:
- 2010
- By:
- Publication type:
- Correction notice
MOLGENIS research: advanced bioinformatics data software for non-bioinformaticians.
- Published in:
- Bioinformatics, 2019, v. 35, n. 6, p. 1076, doi. 10.1093/bioinformatics/bty742
- By:
- Publication type:
- Article
Environmental factors associated with biological use and surgery in inflammatory bowel disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 4, p. 1022, doi. 10.1111/jgh.15223
- By:
- Publication type:
- Article
Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2022, v. 16, n. 3, p. 414, doi. 10.1093/ecco-jcc/jjab157
- By:
- Publication type:
- Article
Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 8, p. 1305, doi. 10.1093/ecco-jcc/jjab008
- By:
- Publication type:
- Article
Isotype-specific Antibody Responses to Mycobacterium avium paratuberculosis Antigens Are Associated With the Use of Biologic Therapy in Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 8, p. 1253, doi. 10.1093/ecco-jcc/jjaa263
- By:
- Publication type:
- Article
Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
- Published in:
- Journal of Crohn's & Colitis, 2020, v. 14, n. 5, p. 595, doi. 10.1093/ecco-jcc/jjz208
- By:
- Publication type:
- Article
Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
- Published in:
- Journal of Crohn's & Colitis, 2019, v. 13, n. 11, p. 1439, doi. 10.1093/ecco-jcc/jjz077
- By:
- Publication type:
- Article
Mucosal host-microbe interactions associate with clinical phenotypes in inflammatory bowel disease.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45855-2
- By:
- Publication type:
- Article
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211012595
- By:
- Publication type:
- Article
Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211012595
- By:
- Publication type:
- Article
Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17504-5
- By:
- Publication type:
- Article
Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13812-y
- By:
- Publication type:
- Article
Gut mucosa dissociation protocols influence cell type proportions and single-cell gene expression levels.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13812-y
- By:
- Publication type:
- Article
Understanding human gut diseases at single-cell resolution.
- Published in:
- Human Molecular Genetics, 2020, v. 29, n. R1, p. R51, doi. 10.1093/hmg/ddaa130
- By:
- Publication type:
- Article
Understanding human gut diseases at single-cell resolution.
- Published in:
- Human Molecular Genetics, 2020, v. 29, n. 16, p. R51, doi. 10.1093/hmg/ddaa130
- By:
- Publication type:
- Article